Damon Desantis Buys 50,000 Shares of INBP
Damon Desantis acquired 50,000 shares of INBP on June 24, 2026.
Key Points
- Damon Desantis purchased 50,000 shares of INBP on June 24, 2026, with shares trading around $0.18.
- The transaction was not part of a pre-planned trading program and involved multiple insiders buying the same amount.
- INBP's stock traded near $0.18 on Thursday, reflecting recent insider buying activity.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Damon Desantis recently purchased 50,000 shares of INBP on June 24, 2026. This insider buying activity was not part of a pre-planned trading program and adds to the interest in the company's stock, which traded near $0.18 on Thursday.
Insider Buying and Selling at Integrated BioPharma, Inc.
On June 24, 2026, several insiders, including Damon Desantis, bought 50,000 shares each of INBP. Other insiders such as Eric Friedman and Robert Canarick made similar purchases on the same day. These transactions were not under Rule 10b5-1 plans, indicating they were not pre-scheduled. Additionally, William Milmoe sold 11,201,964 shares on April 15, 2026, in a separate transaction.
Bottom Line
The recent insider buying at INBP, particularly by Damon Desantis and other key figures, highlights notable interest in the company's stock. Investors often track such transactions to gauge insider confidence. This buying activity offers a glimpse into the internal sentiment at INBP, although it should be noted these transactions are not predictive of future stock performance.
Get Integrated BioPharma, Inc. alerts
New 13F filings, insider trades, and analyst moves on $INBP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.